Hoffman Risa M, Phiri Khumbo, Parent Julie, Grotts Jonathan, Elashoff David, Kawale Paul, Yeatman Sara, Currier Judith S, Schooley Alan
Department of Medicine, Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Partners in Hope Medical Center, Lilongwe, Malawi.
J Int AIDS Soc. 2017 Apr 27;20(1):21464. doi: 10.7448/IAS.20.01.21464.
There are limited data on factors associated with retention in Option B+. We sought to explore the characteristics of women retained in Option B+ in Malawi, with a focus on the role of HIV disclosure, awareness of partner HIV status, and knowledge around the importance of Option B+ for maternal-child health. We performed a case-control study of HIV-infected women in Malawi initiated on antiretroviral therapy (ART) under Option B+. Cases were enrolled if they met criteria for default from Option B+ (out of ART for >60 days), and controls were enrolled in approximately 3:1 ratio if they were retained in care for at least 12 months. We surveyed socio-demographic characteristics, HIV disclosure and awareness of partner HIV status, self-report about receiving pre-ART education, and knowledge of Option B+. Univariate logistic regression was performed to determine factors associated with retention. Multivariate logistic regression model was used to evaluate the relationship between HIV disclosure, Option B+ knowledge, and retention after adjusting for age, schooling, and travel time to clinic.
We enrolled 50 cases and 153 controls. Median age was 30 years (interquartile range (IQR) 25-34), and the majority (82%) initiated ART during pregnancy at a median gestational age of 24 weeks (IQR 16-28). Ninety-one per cent of the cases (39/43) who started ART during pregnancy defaulted by three months postpartum. HIV disclosure to the primary sex partner was more common among women retained in care (100% versus 78%, < 0.001). Odds of retention were significantly higher among women with: age >25 years (odds ratio (OR) 2.44), completion of primary school (OR 3.06), awareness of partner HIV status (OR 5.20), pre-ART education (OR 6.17), higher number of correct answers to Option B+ knowledge questions (OR 1.82), and support while taking ART (OR 3.65). Pre-ART education and knowledge were significantly correlated ( = 0.43, < 0.001). In multivariate analysis, awareness of partner HIV status (OR 4.07, 95% confidence interval (CI) 1.51-10.94, = 0.02) and Option B+ knowledge (OR 1.60, 95% CI 1.15-2.23, = 0.004) remained associated with retention.
Interventions that address partner disclosure and strengthen pre-ART education around the benefits of ART for maternal and child health should be evaluated to improve retention in Malawi's Option B+ programme.
关于与“B+方案”留存率相关因素的数据有限。我们试图探究马拉维采用“B+方案”的留存女性的特征,重点关注艾滋病毒披露情况、对伴侣艾滋病毒感染状况的知晓情况以及对“B+方案”对母婴健康重要性的认知。我们对马拉维接受抗逆转录病毒治疗(ART)的艾滋病毒感染女性进行了一项病例对照研究,这些女性采用“B+方案”。若符合“B+方案”脱漏标准(停止ART治疗超过60天),则纳入病例组;若被护理至少12个月,则按约3:1的比例纳入对照组。我们调查了社会人口学特征、艾滋病毒披露情况和对伴侣艾滋病毒感染状况的知晓情况、关于接受ART治疗前教育的自我报告以及对“B+方案”的了解。进行单因素逻辑回归以确定与留存相关的因素。使用多因素逻辑回归模型评估在调整年龄、受教育程度和到诊所的行程时间后,艾滋病毒披露、“B+方案”知识与留存之间的关系。
我们纳入了50例病例和153名对照。中位年龄为30岁(四分位间距(IQR)25 - 34岁),大多数(82%)在孕期开始接受ART治疗,中位孕周为24周(IQR 16 - 28周)。在孕期开始接受ART治疗的病例中,91%(39/43)在产后三个月脱漏。向主要性伴侣披露艾滋病毒感染情况在留存护理的女性中更为常见(100%对78%,<0.001)。以下女性的留存几率显著更高:年龄>25岁(优势比(OR)2.44)、完成小学教育(OR 3.06)、知晓伴侣艾滋病毒感染状况(OR 5.20)、接受ART治疗前教育(OR 6.17)、对“B+方案”知识问题回答正确的数量较多(OR 1.82)以及在接受ART治疗时有支持(OR 3.65)。ART治疗前教育与知识显著相关(=0.43,<0.001)。在多因素分析中,知晓伴侣艾滋病毒感染状况(OR 4.07,95%置信区间(CI)1.51 - 10.94,=0.02)和“B+方案”知识(OR 1.60,95% CI 1.15 - 2.23,=0.004)仍与留存相关。
应评估旨在解决向伴侣披露问题并加强围绕ART治疗对母婴健康益处的ART治疗前教育的干预措施,以提高马拉维“B+方案”的留存率。